Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Pazhani Sundaram"'
Publikováno v:
HSOA journal of alzheimer's & neurodegenerative diseases
Alzheimer's disease (AD) is the most common cause of dementia, characterized by the deposition of Amyloid-beta (Aβ) plaques in the brain. We have previously developed Amytrap peptide (the active pharmacological ingredient, API) and linked it to a se
Autor:
Omkar Gandbhir, Pazhani Sundaram
Publikováno v:
Journal of Alzheimer's Disease Reports
Alzheimer’s disease (AD) is the most common cause of dementia. Amyloid-β (Aβ42) is implicated in AD pathogenesis. We have designed a non-immune based proprietary therapeutic, called Amytrap, a conjugate containing a retro-inverso peptide, polyeth
Autor:
Pazhani Sundaram, Omkar Gandbhir
Publikováno v:
Journal of Alzheimer's Disease Reports
Alzheimer’s disease (AD) is the most common cause of dementia among elderly patients afflicted by neurodegenerative diseases, caused by the accumulation of amyloid-β (Aβ). Therapeutic interventions in targeting and restricting Aβ production resu
Autor:
Pazhani Sundaram, Omkar Gandbhir
Publikováno v:
Metab Brain Dis
Alzheimer’s Disease (AD) is the most common cause of dementia, affecting 25 million people worldwide. Accumulation of Amyloid-β (Aβ) in the mitochondria has been shown to adversely affect key enzymes including pyruvate dehydrogenase (PDH), succin
Autor:
Pazhani, Sundaram
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1853
Staining of proteins separated on gels provides the basis for determination of the critical properties of these biopolymers, such as their molecular weight and/or charge. Detection of proteins on gels and blots require stains. These stains vary in se
Autor:
Pazhani Sundaram
Publikováno v:
Methods in Molecular Biology ISBN: 9781493987443
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2839713cc0a9f5c8828784b1b8d6b53
https://doi.org/10.1007/978-1-4939-8745-0_1
https://doi.org/10.1007/978-1-4939-8745-0_1
Autor:
Pazhani Sundaram
Publikováno v:
Brain and Nerves. 1
Publikováno v:
International Journal of Peptide Research and Therapeutics. 18:99-106
Alzheimer's Disease (AD), a debilitating neurodegenerative disease is caused by aggregation and accumulation of a 39-43 amino acid peptide (amyloid β or Aβ) in brain parenchyma and cerebrovasculature. The rational approach would be to use drugs tha
Publikováno v:
Current Alzheimer Research. 5:26-32
Alzheimers Disease (AD) is caused by the deposition of insoluble and toxic amyloid peptides (Aβ) in the brain leading to memory loss and other associated neurodegenerative symptoms. To date there is limited treatment options and strategies for treat
Publikováno v:
Recent patents on CNS drug discovery. 9(2)
The primary objective of this article is to review patents and the related scientific work on naturally occurring compounds, heterocyclic compounds and small peptides that are being explored for their utility for the treatment of Alzheimer's disease